Summary We examined the expression of al, a2, a3, a4, a5 and ,B1 integrin on 36 transitional cell cancers (TCCs) in the bladder by immunohistochemistry. Only a2, a3 and /31 were detected on normal transitional cell epithelium, but four TCCs (12.5%) revealed positive staining for al, seven (19.4%) for a4 and seven (20%) for a5. These altered expressions of integrin a chain were more frequent in histologically higher stage or grade of TCC, and a correlation was found between increased aS expression and histological stage. ae5 was positive in 6 (35.3%) of 17 invasive TCCs whereas only 1 (5.9%) of 17 superficial TCCs. Flow cytometric analysis on bladder cancer cell lines showed that T24 and HT1376, which are undifferentiated TCC cell lines, highly expressed aS and P1. Also, SCaBER, which is derived from urinary bladder squamous cell cancer and which is recognised as the most malignant phenotype after metaplasia of transitional epithelium, had aS and P1.However, RT4, which is derived from transitional cell papilloma, showed no expression of a5. Furthermore, reverse transcriptase-polymerase chain reaction (RT-PCR) showed the presence of mRNA of aS on T24, SCaBER and HT1376, but not on RT4. Taken together, it seems that the presence of axS integrin might be a more malignant phenotype in transitional cell carcinoma.Keywords: integrin; VLA-5; transitional cell cancer; immunohistochemistry; flow cytometry; reverse transcriptase-polymerase chain reactionIn the process of tumour invasion and metastasis, the interaction between tumour cells and extracellular matrix (ECM), such as laminin, fibronectin and collagens, has a crucial role (Nicolson and Winkelmake, 1975;Horn and Tang, 1992). This interaction is facilitated through adhesion receptors such as integrins. Integrins are a family of cellsurface proteins that mediate cell adhesion to ECM and signal transduction to the cell interior (Hynes, 1990;Albelda, 1993). They are composed of two subunits, a and ,B, each of which spans the plasma membrane. Distinct a-subunits combine with common or related fl-subunits to form functionally distinct receptors.Integrin distributions have been studied in a number of tissues, including malignant tumours. Recent studies showed that patterns of integrin expression on tumour cells were different compared with normal counterparts and suggested that altered integrin expression may contribute to the invasive or metastatic phenotype. For example, the loss of integrin expression was reported in epithelial neoplasms, such as carcinomas of the breast, colon, pancreas and skin (Pignatelli et al., 1990;Zutter et al., 1990;Hall et al., 1991;Stamp and Pignatelli, 1991). On the other hand, up-regulation of aV#3 was described in malignant melanoma and glioblastoma multiforme, and acquisition of a4#1 has been described in malignant melanoma and renal cell carcinoma (Cheresh et al., 1989;Gladson and Cheresh, 1991;Tomita et al., 1995). In transitional cell carcinoma (TCC), progressive loss of a2 integrin expression from normal urothelial cells through inv...